A Look at the Debut Advocacy Sessions at ENDO 2018

For any Endocrine Society members who want to learn how to advocate on behalf of endocrine science and research, you will get your chance at ENDO 2018 in Chicago!

This year will see the debut of a few new sessions hosted by the Society’s Advocacy and Public Outreach Core Committee (APOCC) and the Government and Public Affairs (GPA) Department, who represents the interests of Endocrine Society members on Capitol Hill, at the White House, with Federal agencies, and to global policymakers.

Here is a look at what attendees can expect to see as they learn how they can become an advocate for policies that will impact patient care and endocrine research:

Engage in Advocacy: Make a Difference for Your Patients, Research, and the Field 

Saturday, March 17 | 12:00-12:50PM, Science Hub

Are you frustrated by what is going on in Washington, D.C.? Join the Advocacy & Public Outreach Core Committee to learn more about the Society’s advocacy agenda and how you can make a difference and advocate for your patients, research, and the field.  We will provide several opportunities for Society members to participate in upcoming advocacy initiatives.

Reducing Outpatient Hypoglycemia – An Emerging National Priority 

Saturday, March 17 | 4:15-5:30PM, W181

Hypoglycemia has been identified as one of the top three preventable adverse drug events (ADEs) by the U.S. Department of Health and Human Services (HHS). While the connection between hypoglycemia and type 1 diabetes is well recognized, the prevalence and consequences of hypoglycemia in patients with type 2 diabetes are often underappreciated. Public and private efforts are being undertaken to raise awareness among healthcare providers, people with diabetes, and caregivers of the risks of hypoglycemia and how to prevent it. Representatives from the Endocrine Society, Food and Drug Administration Safe Use Initiative, and the National Institute of Diabetes and Digestive and Kidney Diseases will highlight ongoing efforts to reduce the incidence of hypoglycemia in the outpatient setting.

Transitioning from Volume to Value under the Quality Payment Program

Monday, March 19 | 1:15-1:55PM, Science Hub

As physicians’ payments are increasingly paid based on the quality of care provided, it is more important than ever to understand how the new Medicare payment system, the Quality Payment Program (QPP), will prioritize value over the volume when determining your payments. This session will provide an overview of Year 2 of the QPP and provide attendees with an opportunity to get answers to their questions on the new system. Join us for a conversation about what the new payment system means for you and how you can set your practice up for success in the new era of value-based payments.

All are welcome to attend. Please join us and help make a difference for your practice, your patients, and your research!

You may also like

  • NIDDK Releases Funding Opportunity Announcements for Type 1 Diabetes Research

    On February 15, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) released 17 long-awaited Funding Opportunity Announcements (FOAs) to support a variety of research projects related to type 1 diabetes and its complications. These FOAs are supported with the recent $150 million extension of the Special Statutory Funding Program for Type 1…